Tuesday, May 10, 2016 5:44:00 AM PDT | VentureDeal
San Jose, California -- Biotechnology platform developer MIODx has landed $1.5 million in seed stage venture capital funding.
MIODx says that it is "pioneering the discovery of early detection and prognostic cancer biomarkers through its proprietary platforms." Investors in the financing were not disclosed, nor was how the company intends to use the funding proceeds. CEO Allen Northrup has been with the firm since March 2014. Sean Givens is the co-founder and COO of the company.
Email Page | Print Page
Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?
Start your Free 14 Day Trial now – no obligation or credit card required.
